Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Lanes Health rebrand pushes rose-hip compound for joints

Lanes Health has rebranded its supplement for chronic joint conditions to highlight that it contains rose-hip compound GOPO.

The company changed the supplement's name from Litozin Joint Health to GOPO last month, to show it contained a "scientifically proven formula", said Lanes Health.

Clinical trials had shown rose-hip with a level of GOPO (the active compound isolated from rose-hip rosa canina) helped conditions such as osteoarthritis and rheumatoid arthritis in clinical trials, it said.

It is the only UK company to distribute supplements containing GOPO, it added. "With an increasing number of unproven rose-hip based supplements flooding the UK market, we felt it was an opportune time to rebrand and make it easier for consumers who had read about the efficacy of GOPO to find it in-store," said sales and marketing director Dave Cole.

There is no change to the formula of the capsules but the retail price has dropped from £20.42 for 120 capsules to £17.99. A pack of 200 capsules will be £26.99.

For more information, contact Lanes Health on 01452 524012

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD016127

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel